The following report is the second edition of our global guide to leading conferences pertaining to artificial intelligence in pharma for 2019 and 2020.
Its purpose is to enable academics, investors, scientists, politicians and technologists, as well as interested general public, to participate more readily in the emerging industry by identifying affordable events at venues near to them.
35 conferences have been included, based on following criteria:
The event must be well attended, with a large number of speakers as well as participants.
It must include at least one panel on the application of AI to drug discovery.
Speakers must include pharmaceutical corporations (e.g., Johnson & Johnson, Merck, etc.) and/or technology corporations (such as IBM or Microsoft) in order to be relevant. Such corporations are the main engines driving the development of AI in drug discovery, and the primary end-users of technologies currently being developed by AI startups.
The conferences we identify also have the following in common:
They all include AI startups.
They all include scientists and scholars who are helping AI specialists to develop efficient technologies, and academia is well represented.
The vast majority take a place in US or UK, however several of them will be in Asia, mainly SIngapore and China.
This is an experimental attempt to catalog these conferences. We expect to enlarge the length and scope of future editions.